Additional file 2 of Antiplatelet drugs for secondary prevention in patients with ischemic stroke or transient ischemic attack: a systematic review and network meta-analysis

Additional file 2. League tables from the main analysis for primary and secondary outcomes, from the subgroup analysis for major bleeding and from the sensitivity analysis for primary outcomes. Treatments are reported in the diagonal. Results are reported as odds ratio and relative 95% confidence interval. Comparisons must be read from left to right. On the triangle under the diagonal, an estimate less than 1 favor the column-defining treatment. On the triangle upper the diagonal, an estimate more than 1 favor the row-defining treatment. Significant results are in bold (only in the lower triangle).